GeneOne Life Science, Inc. Q3 operating loss of KRW 5.4 billion on revenue of KRW 1.8 billion
GeneOne Life Science, Inc.· Periodic Report
AI summary · Not investment advice
In Q3, the company sold KRW 1.8 billion and lost KRW 5.4 billion from its main business, versus a KRW 11.7 billion loss a year earlier.
Operating profit · 3 months
KRW -5.4 billion
Key facts
- Revenue (3 months)
- KRW 1.8 billion
- Net income (3 months)
- KRW -15.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 5.1 billion
- Revenue (year to date)
- KRW 6.4 billion
- Operating profit (prior-year 3 months)
- KRW -11.7 billion
- Operating profit (year to date)
- KRW -20.6 billion
- Net income (prior-year 3 months)
- KRW -11.5 billion
- Net income (year to date)
- KRW -36.7 billion
Earlier Periodic Report filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.05.152026.05.15 | [Amended] Periodic Report | KRW -2.3 billion |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G